126 related articles for article (PubMed ID: 7888830)
1. Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation.
Boiron JM; Cony-Makhoul P; Mahon FX; Pigneux A; Puntous M; Reiffers J
Blood Rev; 1994 Dec; 8(4):234-40. PubMed ID: 7888830
[TBL] [Abstract][Full Text] [Related]
2. Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties.
Kolb HJ
Vox Sang; 1998; 74 Suppl 2():321-9. PubMed ID: 9704463
[TBL] [Abstract][Full Text] [Related]
3. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Schaefer UW
Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Samuel S; Kapelushnik J; Brautbar C; Or R
Blood; 1996 Mar; 87(6):2195-204. PubMed ID: 8630379
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantation.
Kumar L
Leuk Lymphoma; 1993 Jun; 10(3):165-71. PubMed ID: 8220114
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
7. Leukemia: management of relapse after allogeneic bone marrow transplantation.
Kumar L
J Clin Oncol; 1994 Aug; 12(8):1710-7. PubMed ID: 8040682
[TBL] [Abstract][Full Text] [Related]
8. Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
Min CK; Eom KS; Lee S; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2001 May; 27(9):999-1005. PubMed ID: 11436112
[TBL] [Abstract][Full Text] [Related]
9. Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis.
Leber B; Walker IR; Rodriguez A; McBride JA; Carter R; Brain MC
Bone Marrow Transplant; 1993 Oct; 12(4):405-7. PubMed ID: 8275041
[TBL] [Abstract][Full Text] [Related]
10. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
Szer J; Grigg AP; Phillips GL; Sheridan WP
Bone Marrow Transplant; 1993 Feb; 11(2):109-11. PubMed ID: 8435660
[TBL] [Abstract][Full Text] [Related]
11. What does one do for the CML patient in relapse after allogeneic bone marrow transplantation?
Arcese W; Iori AP; Di Nucci G; Martinez-Rolon J; Pinto RM; Mandelli F
Leuk Lymphoma; 1993; 11 Suppl 1():213-9. PubMed ID: 8251899
[TBL] [Abstract][Full Text] [Related]
12. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
Giralt SA; LeMaistre CF; Vriesendorp HM; Andersson BS; Dimopoulos M; Gajewski J; Van Besien K; Mehra R; Przepiorka D; Khouri I
J Clin Oncol; 1994 Sep; 12(9):1923-30. PubMed ID: 8083714
[TBL] [Abstract][Full Text] [Related]
13. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
14. Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation.
Wassmann B; Klein SA; Scheuring U; Pfeifer H; Martin H; Gschaidmeier H; Hoelzer D; Ottmann OG
Bone Marrow Transplant; 2001 Oct; 28(7):721-4. PubMed ID: 11704799
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
16. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation.
Levine JE; Braun T; Penza SL; Beatty P; Cornetta K; Martino R; Drobyski WR; Barrett AJ; Porter DL; Giralt S; Leis J; Holmes HE; Johnson M; Horowitz M; Collins RH
J Clin Oncol; 2002 Jan; 20(2):405-12. PubMed ID: 11786567
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
Hertenstein B; Wiesneth M; Novotny J; Bunjes D; Stefanic M; Heinze B; Hübner G; Heimpel H; Arnold R
Transplantation; 1993 Nov; 56(5):1114-8. PubMed ID: 8249110
[TBL] [Abstract][Full Text] [Related]
18. Leukemia relapse after allogeneic bone marrow transplantation: a review.
Giralt SA; Champlin RE
Blood; 1994 Dec; 84(11):3603-12. PubMed ID: 7949117
[No Abstract] [Full Text] [Related]
19. [Current aspects of therapy in chronic and acute leukemias].
Seipelt G; Hoelzer D
Schweiz Med Wochenschr; 1995 Jul; 125(27-28):1354-63. PubMed ID: 7624746
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
